About Us

section-5a47de0
https://infugenpharma.com/wp-content/uploads/2025/01/about-us-600x800.jpg
https://infugenpharma.com/wp-content/uploads/2024/10/About-Us-50x50.png

About us

Since our inception in 1999 with a small base, we have grown significantly as one of the First leading Contract Manufacturing Services Organisation (CMSO), we bring unparalleled value to our partners by setting new benchmarks in contract manufacturing services in the healthcare sector, with over 30 years of experience. As the leading CMSO, we focus on serving end-to-end solutions, offering seamless integration of product development, manufacturing, and supply chain management.

India is home to approximately 12,000 pharmaceutical manufacturing units, with around 2,000 to 3,000 units holding WHO-GMP prequalification. We are committed to collaborating with these esteemed manufacturers, leveraging their expertise and capabilities to enhance our product offerings and ensure compliance with global quality standards.

We have recently been accredited as WHO GMP certified for our oncology unit, which has the capacity of 5 lac tablets, 10 lac capsules, 2 lac vet tabs per shift & so on. As one of the fastest-growing export houses, we take pride in our expansive portfolio of over 100+ products, available in more than 25+ countries.

Infugen is also associated with other specialized formulation manufacturing units to achieve our commitment and vision. We, Infugen Pharma, with our diverse product range, bridge the gap between innovation and affordability in pharmaceutical formulations, medical, and surgical devices. Our global reach extends to North and East Africa, French West Africa, Southeast Asia, Central America, the Caribbean regions, and CIS countries, where we support our partners with reliable healthcare solutions and prioritize underserved communities to improve lives worldwide.

We are a trusted strategic partner for various government procurement agencies such as CMAM, RMS, NIPDEC, NDSO, OECS, NPSP, JMS, NMS, SPC (Sri Lanka), and SPMC (Sri Lanka), delivering value-added services to our overseas customers.

Infugen is focused on the expansion of strategic business worldwide, with the aim of securing approvals to provide effective global healthcare access and contribute to better health outcomes with our highly qualified and experienced Quality Technical.

section-5489b78
vissionImg
VISION

inverted2ndTo be the leader in contract manufacturing services, making high-quality pharmaceuticals and medical devices accessible and affordable. We aim to improve the quality of life worldwide through reliable and sustainable partnerships.inverted1st

straightLine
missionImg
MISSION

inverted2ndFulfilling our vision of enabling global healthcare access, we bridge the gap between affordability by providing high-quality, reliable, and cost-effective contract manufacturing solutions. We partner with pharmaceutical and medical device companies to develop and deliver life-changing products worldwide, prioritizing speed, quality, and compliance to improve lives and support underserved communities.inverted1st

section-4958089

Milestones and Achievements of Infugen Pharma Pvt. Ltd

30th April, 1987
Yamuna distributor was established in Sangli
24th May, 1996
Shree Krishna Distributor was established in Miraj
04th Feb, 1999
Incorporation of Jeshika Pharma Pvt. Ltd (now known as Infugen Pharma Pvt. Ltd)
2009
International expansion with first export to Mozambique

2012
First registration in CIS market
2013
First registration in South East Asia market
2017-18
Recognized as one-star export house
2019
First registration in African market


2020-21
Sales growth up to 300%
2022

International expansion in Central America.

Incorporation of Infugen Lifesciences (subsidiary of Infugen Pharma Pvt. Ltd)

2023

WHO GMP certification for Infugen Pharma.

Successfully registered 100th products.

2024

INFUTRAX brand registered in 7 countries

INFIXIME brand registered in 5 countries